Healthcare Data Monetization Solutions Market Size, Share and Trends 2025 to 2034

Healthcare Data Monetization Solutions Market Size and Forecast 2025 to 2034

The global healthcare data monetization solutions market size was calculated at USD 921.04 million in 2024 and is predicted to reach around USD 4,077.14 million by 2034, expanding at a CAGR of 16.04% from 2025 to 2034. The growing need to leverage patient information, medical records, and clinical insights, which help generate revenue or value for healthcare organizations, is increasing the demand for the healthcare data monetization solutions market.

Healthcare Data Monetization Solutions Market Key Takeaways

• North America dominated the global market with the largest market share of 42% in 2024.
• Europe is anticipated to grow at the fastest CAGR during the projected period.
• By type, the indirect data monetization segment contributed the highest market share in 2024.
• By type, the direct data monetization segment is anticipated to grow at the fastest CAGR from 2025 to 2034.
• By facility size, the large facilities segment contributed the highest market share in 2024.
• By facility size, the small and medium facilities segment is predicted to grow at a remarkable CAGR during the forecast period.
• By end use, the healthcare payers segment captured the largest market share of 44% in 2024.
• By end use, the life science companies segment is expected to grow rapidly during the forecast period.
• By mode of deployment, the cloud segment generated the major market share in 2024.
• By mode of deployment, the on-premise segment is estimated to show the fastest growth during the forecast period.

How is Artificial Intelligence (AI) Changing the Healthcare Data Monetization Solutions Market?

Integration of artificial intelligence in the healthcare data monetization solutions market has the potential to bring advanced technology. Along with that, healthcare is becoming a data-driven industry. AI is anticipated to play a crucial role in data monetization by providing personalized medicine, improving operational efficiency, bring preventative care programs and collaborative partnerships. These advancements are expected to leverage healthcare data by improving patient care and bringing innovations. Additionally, AI can also used to support digital communication, offer schedule reminders, design help tips, and suggest next steps to patients. These characteristics of AI will help with better diagnosis and improve the speed and accuracy of patient visits, resulting in faster and more personalized care.

• In July 20204, OMNY Health, a company that connects patients, providers, and life sciences companies through data and insights, launched an AI-powered platform for health technology companies to leverage its data on more than 75 million patients. The company believes that the collaboration will help QuantHealth's pharma partners speed up drug development through simulated clinical trials and predict clinical trial outcomes, patient responses, and drug efficacy.

U.S. Healthcare Data Monetization Solutions Market Size and Growth 2025 to 2034

The U.S. healthcare data monetization solutions market size was exhibited at USD 309.47 million in 2024 and is projected to be worth around USD 1,394.89 million by 2034, growing at a CAGR of 16.25% from 2025 to 2034.

North America dominated the global healthcare data monetization solutions market in 2024S, owing to the advanced healthcare infrastructure and investment in technology. The American Hospital Association reports 1887 hospital mergers in the past decade, contributing to reshaping the U.S. healthcare industry. The Centers for Medicare and Medicaid Services (CMS) provide data as a means to enable researchers and policymakers to gain deeper insights into how mergers, acquisitions, consolidation, and changes of ownership affect access to care, cost, and quality. The main healthcare system notices in the U.S. and Western society include the Beveridge model, the Bismarck model, the national health insurance model, and the out-of-pocket model.

Europe is anticipated to grow at the fastest CAGR in the healthcare data monetization solutions market during the projected period due to supportive government policies and increasing awareness regarding the growing opportunities of data monetization.  With digital adoption, the region’s government has implemented a regulatory system. The region has benefited from data generation in formulating various acts and policies throughout the states, incorporating data protection, data security, data privacy, and data sharing to reduce the risk of cyber threats and other branches. The government establishes various processes to enhance collaboration and flow data to improve the industry ecosystem.

Market Overview

Healthcare data monetization solutions market solutions are different ways to utilize patient data to create economic value for healthcare organizations. This is achieved by improving internal processes, selling and sharing data, developing personalized medicine, or collecting data from a remote device. The application of healthcare data monetization helps enhance patient outcomes, increase operational efficiency, reduce cost, and increase business values. However, the monetization of data by industries should be performed ethically, securely, and effectively. Healthcare data includes electronic health records (EHR), medical Imaging, and many more. The process of monetizing healthcare data encompasses various strategies such as personalized medicine, AI-driven operation improvement, anonymized data sales, preventative care programs, collaboration with health technology innovations, and advanced analytics.

• According to the healthcare division at global investment bank, RBC Capital Markets, around 30% of the world’s data volume is generated by the healthcare industry. By 2025, it is estimated that the annual growth rate will reach 36%.

Healthcare Data Monetization Solutions Market Growth Factors

• Boost revenue growth: The healthcare data monetization solutions market is encouraging organizations to leverage their data assets and artificial intelligence capabilities which will lead to economic returns. Increasing availability of data offers a pathway for the development of innovation, targeted products, and services that cater to specific needs.
• Accelerate performance and simplify processes: Healthcare data monetization allows companies to enhance workflow productivity with a thorough analysis of performance data. This also helps narrow down and streamline complex processes and tailor effective training programs for employee needs and for organizations to optimize performance.
• Reduce infrastructure costs: Data monetization helps with the company’s revenue and optimizes IT infrastructure. Through cloud-based analytics and strong solutions, a firm can efficiently manage and scale its data capabilities.
• Decrease operating expenses: Data-driven information encourages organizations to make informed and strategic decisions which will lead to optimizing budget allocation and reducing wastage.

Market Scope

Market Dynamics

Driver

Real-world evidence

Rising demand for real-world evidence in the healthcare industry is proliferating the growth of the healthcare data monetization solutions market. Real-world data is a set of information on a patient's health status and the delivery of a healthcare routine, which is collected from a variety of sources. Real-world data (RWE) includes data collected from electronic health records, medical claims data, data from product or disease registries, and many more. This is proven evidence about the usage and potential benefits or risks of a medical product derived from a studied RWE, understanding drugs, and routine clinical practice. RWE helps to provide a deeper understanding of how interventions perform on diverse patient populations, assess the cost and effectiveness of treatment, monitor for side effects, and provide data on rare diseases. Moreover, this revolutionized help in the healthcare industry in drug development.

Restraint

Risks associated with healthcare data

As healthcare data is extremely sensitive, a breach in the data can lead to loss of reputation, cost lawsuits, and patient privacy will be exposed. The healthcare data monetization solutions market holds the sole responsibility to protect the collected data, aggregates, and potentially shares. This data represents a significant accountability for both security and legal terms. Therefore, direct monetization requires careful analysis of the risks, benefits, and actions of monetizing special medical data.

• In 2023, in the United States, CommonSpirit Health, the second largest health system in the U.S., was hit by a class-action lawsuit alleging negligence for a ransomware attack that saw 600,000 compromised.

Opportunity

Personalized medicine and genomics

The future of the healthcare data monetization solutions market is anticipated to bring immense promise for transforming the deliverance and experience of healthcare. Personalized medicine is constantly evolving in the healthcare industry, and it uses patients' genetic profiles to make medical decisions. Genomics is a main component of personalized medicine. The application of these technologies in data monetization is expected to enhance the understanding of disease and its molecular mechanisms, resulting in enhancing the capacity of personalized interventions. Personalized genomic medicines have the potential to classify complex diseases and discover more specific treatments based on genomics.

Type Insights

The indirect data monetization segment contributed the highest share of the healthcare data monetization solutions market in 2024. The dominance of this segment is observed as the data does not leave the organization. It is used to build better-personalized healthcare plans for patients and digitally empower the patient to take an active part in their health and wellbeing. The indirect data monetization approach in the healthcare industry uses analytics to get valuable insights to enhance internal processing, products, and services.

The direct data monetization segment is anticipated to grow at the fastest CAGR from 2025 to 2034. The growth of this segment is experienced as this helps in building revenue streams by selling data to third parties, setting up data-as-a-service, or creating personalized products and services for key demographics with partners. Several pharmaceutical companies are launching schemes to share research data which will be helpful in transforming diagnosis and development of customized medicines.

Facility Size Insights

The large facilities segment captured the biggest share of the healthcare data monetization solutions market in 2024. This segment deals with the key leaders in the healthcare industry, such as academic medical centers and major hospitals. These facilities offer resources to invest in advanced data monetization solutions, which help with obtaining knowledge that is used in complex analytics, artificial intelligence, and data processing tools. In addition, it helps support research and collaboration with other stakeholders in the healthcare landscape.

On the other hand, the small and medium facilities segment is anticipated to grow at a significant CAGR during the forecast period. The increasing adoption of healthcare data monetization in small & medium facilities is observed as it improves operation efficacy using real-time data, generates revenue streams by selling data as a service, collaborates with larger entities, adopts new technologies, and meets customer needs.

End-use Insights

The healthcare payers segment captured the biggest share of the healthcare data monetization solutions market in 2024. The dominance of this segment is noticed as healthcare payer such as health insurers are driving forces in the healthcare ecosystem and adapting to data monetization to improve the value of healthcare and accessibility for their member. Healthcare payers use patient records for research, personalized medicine, and improving patient outcomes. It has also contributed to population health management by identifying at-risk patients and developing target interventions to improve their health results.

The life science companies segment is expected to grow rapidly during the forecast period. The growth of this segment is observed as life science companies play a vital role in the healthcare industry through research and development and manufacturing of products and technologies that help to improve health outcomes. Life science companies include biotechnology experts, medical device developers, and pharmaceutical manufacturers. The key role in the healthcare industry is to provide a possible treatment, cure the patient, and provide health-related benefits such as death claims and life insurance policies.

Mode of Deployment Insights

The cloud segment led the global healthcare data monetization solutions market in 2024. The cloud-based solution allows healthcare organizations to securely store, manage, and analyze the data. Cloud computing in the healthcare industry helps to enable real-time monitoring, improved patient outcomes, and enhanced healthcare administration by controlling interconnected devices. Additionally, it supports building and deployment of healthcare platforms.

The on-premise segment is estimated to show the fastest growth in the market during the forecast period. One-premise data monetization system in healthcare provides seamless integration with electronic health records or claim management platforms. Along with that, this offers a tailored system to tend specific needs of healthcare payers. The growth of this segment is associated with the complete control it offers over healthcare infrastructure and data, and no internet connection means no interruption to accessing patient records.

Healthcare Data Monetization Solutions Market Companies

• Oracle Corporation
• Microsoft Corporation
• Google
• Salesforce, Inc.
• SAS Institute Inc.
• SAP SE
• TIBCO Software Inc.
• Sisense Inc.
• McKesson Corporation
• Siemens AG
• Accenture Plc
• GE Healthcare
• Infosys Limited
• Cerner Corporation
• OpenText Corporation

Latest Announcements by Industry Leaders

• In October 2024, Seema Verma, executive vice president and general manager of Oracle Health and Life Sciences, said, “Oracle Health Data Intelligence works with any EHR, and we are proud to make this available to all health systems. This not only eliminates the blind spots resulting from data silos, but it also uses advances in AI to enable healthcare organizations to be more predictive and proactive in their approach to care plans and reporting” She further added, “This enables clinical, care management, and financial teams to identify and address potential problems before they develop—reducing costs, increasing reimbursements, closing care gaps, and improving population health.”

Recent Developments

• In December 2024, Atropos Health, a leader in translating clinical data into high-quality, personalized, real-world evidence (RWE) for care, launched the AI model training on Atropos Evidence Network, the largest federated healthcare data network with more than 200 million patient records. The aim is to utilize certain de-identified real-world data (RWD) to train AI models and seamlessly deploy their technology via channel partner systems, including pharmaceutical companies and health systems such as Stanford.
• In October 2024, Datma, a leading provider of federated Real-World Data platforms and related analytical tools, officially launched a datma.FED- an innovative two-sided marketplace designed to revolutionize the sharing, accessibility, and monetization of healthcare data. The aim is to bridge the gap between health systems and reference labs on one side and pharmaceutical companies and research organizations on the other side, creating a symbiotic ecosystem.

Segments Covered in the Report

By Type

• Direct Data Monetization
  • Software
  • Services
• Indirect Data Monetization
  • Software
  • Services

By Mode of Deployment

• On-Premises
• Cloud

By Facility Size

• Small and Medium Facilities
• Large Facilities

By End-use

• Healthcare Payers
• Life Science Companies
• Healthcare Providers

By Geography

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa